1
|
Zuelgaray E, Chevret S, Jachiet M, Cacoub P, Kahn JE, Groh M, Granel B, Scafi M, Geffray L, Chasset F, Gatfosse M, Mekinian A, Lioger B, Mahr A, Gaches F, Michaud M, Ludot I, Cordoliani F, de Masson A, Cassius C, Retornaz F, Audemard-Verger A, Lartigau-Roussin C, Roriz M, Chaigne B, Pallure V, Marie I, Castel B, Loustau V, Chiche L, Gavand PE, Cathebras P, Barete S, Frances C, Brenaut E, Allenbach Y, Benveniste O, Noel N, Urbanski G, Hinschberger O, Bessis D, Bagot M, Bouaziz JD, Sène D. Trunk involvement and peau d'orange aspect are poor prognostic factors in eosinophilic fasciitis (Shulman disease): A multicenter retrospective study of 119 patients. J Am Acad Dermatol 2023; 88:160-163. [PMID: 33188872 DOI: 10.1016/j.jaad.2020.11.009] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2020] [Revised: 11/05/2020] [Accepted: 11/05/2020] [Indexed: 11/28/2022]
Affiliation(s)
- Elina Zuelgaray
- Service de Dermatologie, Université de Paris, Hôpital Saint-Louis, Paris, France
| | - Sylvie Chevret
- Service de Biostatistique et Information Médicale, Université de Paris, Hôpital Saint-Louis, Paris, France
| | - Marie Jachiet
- Service de Dermatologie, Université de Paris, Hôpital Saint-Louis, Paris, France
| | - Patrice Cacoub
- Département de Médecine Interne et d'Immunologie clinique, Sorbonne-Université, Hôpital de la Pitié-Salpêtrière, APHP, Paris, France
| | - Jean-Emmanuel Kahn
- Centre National de Référence des Syndromes Hyperéosinophiliques, Service de Médecine Interne, Hôpital Foch, Suresnes, France
| | - Matthieu Groh
- Centre National de Référence des Syndromes Hyperéosinophiliques, Service de Médecine Interne, Hôpital Foch, Suresnes, France
| | - Brigitte Granel
- Service de Médecine Interne et d'Immunologie clinique, Hôpital Nord, Marseille, France
| | - Manon Scafi
- Service de Médecine Interne et d'Immunologie clinique, Hôpital Nord, Marseille, France
| | - Loïk Geffray
- Service de Médecine Interne et d'Immunologie clinique, Centre Hospitaliser de Lisieux, Lisieux, France
| | - François Chasset
- Service de Dermatologie, Université de Paris, Hôpital Tenon, Paris, France
| | - Marc Gatfosse
- Service de Médecine Interne et d'Immunologie clinique, Sorbonne Université, Hôpital Saint-Antoine, Paris, France
| | - Arsène Mekinian
- Service de Médecine Interne et d'Immunologie clinique, Sorbonne Université, Hôpital Saint-Antoine, Paris, France
| | - Bertrand Lioger
- Unité de Médecine Interne et Maladies systémiques, Université de Paris, Hôpital Saint-Louis, Paris, France
| | - Alfred Mahr
- Unité de Médecine Interne et Maladies systémiques, Université de Paris, Hôpital Saint-Louis, Paris, France
| | - Francis Gaches
- Service de Médecine Interne et d'Immunologie clinique, Hôpital Joseph Ducuing, Toulouse, France
| | - Martin Michaud
- Service de Médecine Interne et d'Immunologie clinique, Hôpital Joseph Ducuing, Toulouse, France
| | - Isabelle Ludot
- Service de Rhumatologie, Clinique Pasteur, Toulouse, France
| | - Florence Cordoliani
- Service de Dermatologie, Université de Paris, Hôpital Saint-Louis, Paris, France
| | - Adèle de Masson
- Service de Dermatologie, Université de Paris, Hôpital Saint-Louis, Paris, France
| | - Charles Cassius
- Service de Dermatologie, Université de Paris, Hôpital Saint-Louis, Paris, France
| | - Frédérique Retornaz
- Unité de soins et de recherche en médecine interne et de maladies infectieuses, Hôpital Européen, Marseille, France
| | - Alexandra Audemard-Verger
- Service de Médecine Interne et d'Immunologie clinique, Centre Hospitalo-Universitaire Côte de Nacre, Caen, France
| | - Céline Lartigau-Roussin
- Service de Médecine Interne et d'Immunologie clinique, Centre Hospitalier Ouest Réunion, Saint Paul, France
| | - Mélanie Roriz
- Service de Médecine Interne et d'Immunologie clinique, Hôpital Bichat, Paris, France
| | - Benjamin Chaigne
- Service de Médecine Interne et d'Immunologie clinique, Hôpital Cochin, Paris, France
| | - Valérie Pallure
- Service de Dermatologie, Centre Hospitalier de Perpignan, Perpignan, France
| | - Isabelle Marie
- Service de Médecine Interne et d'Immunologie clinique, Centre Hospitalo-Universitaire de Rouen, Rouen, France
| | - Brice Castel
- Service de Médecine Interne et d'Immunologie clinique, Centre Hospitalier de Lourdes, Lourdes, France
| | - Valentine Loustau
- Service de Médecine Interne et d'Immunologie clinique, Centre Hospitalier Alpes Léman, Contamine-sur-Avre, France
| | - Laurent Chiche
- Unité de soins et de recherche en médecine interne et de maladies infectieuses, Hôpital Européen, Marseille, France
| | - Pierre-Edouard Gavand
- Service de Médecine Interne et d'Immunologie clinique, Clinique Rhena, Strasbourg, France
| | - Pascal Cathebras
- Service de Médecine Interne et d'Immunologie clinique, Centre Hospitalo-Universitaire de Saint Etienne, Hôpital Nord, Saint-Etienne, France
| | - Stéphane Barete
- Service de Dermatologie, Hôpital de la Pitié-Salpêtrière, Paris, France
| | - Camille Frances
- Service de Dermatologie, Université de Paris, Hôpital Tenon, Paris, France
| | - Emilie Brenaut
- Service de Dermatologie, Centre Hospitalo-Universitaire Morvan, Brest, France
| | - Yves Allenbach
- Département de Médecine Interne et d'Immunologie clinique, Sorbonne-Université, Hôpital de la Pitié-Salpêtrière, APHP, Paris, France
| | - Olivier Benveniste
- Département de Médecine Interne et d'Immunologie clinique, Sorbonne-Université, Hôpital de la Pitié-Salpêtrière, APHP, Paris, France
| | - Nicolas Noel
- Service de Médecine Interne et d'Immunologie clinique, Hôpital Bicêtre, Kremlin-Bicêtre, France
| | - Geoffrey Urbanski
- Service de Médecine Interne et d'Immunologie clinique, Centre Hospitalo-Universitaire d'Angers, Angers, France
| | - Olivier Hinschberger
- Service de Médecine Interne et d'Immunologie clinique, Hôpital Emile Muller, Mulhouse, France
| | - Didier Bessis
- Service de Dermatologie, Hôpital Saint Eloi, Montpellier, France
| | - Martine Bagot
- Service de Dermatologie, Université de Paris, Hôpital Saint-Louis, Paris, France
| | - Jean-David Bouaziz
- Service de Dermatologie, Université de Paris, Hôpital Saint-Louis, Paris, France.
| | - Damien Sène
- Service de Médecine Interne et d'Immunologie clinique, Hôpital Lariboisière, Paris, France
| | | | | | | |
Collapse
|
2
|
Wymant C, Bezemer D, Blanquart F, Ferretti L, Gall A, Hall M, Golubchik T, Bakker M, Ong SH, Zhao L, Bonsall D, de Cesare M, MacIntyre-Cockett G, Abeler-Dörner L, Albert J, Bannert N, Fellay J, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos RD, Laeyendecker O, Meyer L, Porter K, Ristola M, van Sighem A, Berkhout B, Kellam P, Cornelissen M, Reiss P, Fraser C, Aubert V, Battegay M, Bernasconi E, Böni J, Braun DL, Bucher HC, Burton-Jeangros C, Calmy A, Cavassini M, Dollenmaier G, Egger M, Elzi L, Fehr J, Fellay J, Furrer H, Fux CA, Gorgievski M, Günthard H, Haerry D, Hasse B, Hirsch HH, Hoffmann M, Hösli I, Kahlert C, Kaiser L, Keiser O, Klimkait T, Kouyos R, Kovari H, Ledergerber B, Martinetti G, de Tejada BM, Marzolini C, Metzner K, Müller N, Nadal D, Nicca D, Pantaleo G, Rauch A, Regenass S, Rudin C, Schöni-Affolter F, Schmid P, Speck R, Stöckle M, Tarr P, Trkola A, Vernazza P, Weber R, Yerly S, van der Valk M, Geerlings SE, Goorhuis A, Hovius JW, Lempkes B, Nellen FJB, van der Poll T, Prins JM, Reiss P, van Vugt M, Wiersinga WJ, Wit FWMN, van Duinen M, van Eden J, Hazenberg A, van Hes AMH, Rajamanoharan S, Robinson T, Taylor B, Brewer C, Mayr C, Schmidt W, Speidel A, Strohbach F, Arastéh K, Cordes C, Pijnappel FJJ, Stündel M, Claus J, Baumgarten A, Carganico A, Ingiliz P, Dupke S, Freiwald M, Rausch M, Moll A, Schleehauf D, Smalhout SY, Hintsche B, Klausen G, Jessen H, Jessen A, Köppe S, Kreckel P, Schranz D, Fischer K, Schulbin H, Speer M, Weijsenfeld AM, Glaunsinger T, Wicke T, Bieniek B, Hillenbrand H, Schlote F, Lauenroth-Mai E, Schuler C, Schürmann D, Wesselmann H, Brockmeyer N, Jurriaans S, Gehring P, Schmalöer D, Hower M, Spornraft-Ragaller P, Häussinger D, Reuter S, Esser S, Markus R, Kreft B, Berzow D, Back NKT, Christl A, Meyer A, Plettenberg A, Stoehr A, Graefe K, Lorenzen T, Adam A, Schewe K, Weitner L, Fenske S, Zaaijer HL, Hansen S, Stellbrink HJ, Wiemer D, Hertling S, Schmidt R, Arbter P, Claus B, Galle P, Jäger H, Jä Gel-Guedes E, Berkhout B, Postel N, Fröschl M, Spinner C, Bogner J, Salzberger B, Schölmerich J, Audebert F, Marquardt T, Schaffert A, Schnaitmann E, Cornelissen MTE, Trein A, Frietsch B, Müller M, Ulmer A, Detering-Hübner B, Kern P, Schubert F, Dehn G, Schreiber M, Güler C, Schinkel CJ, Gunsenheimer-Bartmeyer B, Schmidt D, Meixenberger K, Bannert N, Wolthers KC, Peters EJG, van Agtmael MA, Autar RS, Bomers M, Sigaloff KCE, Heitmuller M, Laan LM, Ang CW, van Houdt R, Jonges M, Kuijpers TW, Pajkrt D, Scherpbier HJ, de Boer C, van der Plas A, van den Berge M, Stegeman A, Baas S, Hage de Looff L, Buiting A, Reuwer A, Veenemans J, Wintermans B, Pronk MJH, Ammerlaan HSM, van den Bersselaar DNJ, de Munnik ES, Deiman B, Jansz AR, Scharnhorst V, Tjhie J, Wegdam MCA, van Eeden A, Nellen J, Brokking W, Elsenburg LJM, Nobel H, van Kasteren MEE, Berrevoets MAH, Brouwer AE, Adams A, van Erve R, de Kruijf-van de Wiel BAFM, Keelan-Phaf S, van de Ven B, van der Ven B, Buiting AGM, Murck JL, de Vries-Sluijs TEMS, Bax HI, van Gorp ECM, de Jong-Peltenburg NC, de Mendonç A Melo M, van Nood E, Nouwen JL, Rijnders BJA, Rokx C, Schurink CAM, Slobbe L, Verbon A, Bassant N, van Beek JEA, Vriesde M, van Zonneveld LM, de Groot J, Boucher CAB, Koopmans MPG, van Kampen JJA, Fraaij PLA, van Rossum AMC, Vermont CL, van der Knaap LC, Visser E, Branger J, Douma RA, Cents-Bosma AS, Duijf-van de Ven CJHM, Schippers EF, van Nieuwkoop C, van Ijperen JM, Geilings J, van der Hut G, van Burgel ND, Leyten EMS, Gelinck LBS, Mollema F, Davids-Veldhuis S, Tearno C, Wildenbeest GS, Heikens E, Groeneveld PHP, Bouwhuis JW, Lammers AJJ, Kraan S, van Hulzen AGW, Kruiper MSM, van der Bliek GL, Bor PCJ, Debast SB, Wagenvoort GHJ, Kroon FP, de Boer MGJ, Jolink H, Lambregts MMC, Roukens AHE, Scheper H, Dorama W, van Holten N, Claas ECJ, Wessels E, den Hollander JG, El Moussaoui R, Pogany K, Brouwer CJ, Smit JV, Struik-Kalkman D, van Niekerk T, Pontesilli O, Lowe SH, Oude Lashof AML, Posthouwer D, van Wolfswinkel ME, Ackens RP, Burgers K, Schippers J, Weijenberg-Maes B, van Loo IHM, Havenith TRA, van Vonderen MGA, Kampschreur LM, Faber S, Steeman-Bouma R, Al Moujahid A, Kootstra GJ, Delsing CE, van der Burg-van de Plas M, Scheiberlich L, Kortmann W, van Twillert G, Renckens R, Ruiter-Pronk D, van Truijen-Oud FA, Cohen Stuart JWT, Jansen ER, Hoogewerf M, Rozemeijer W, van der Reijden WA, Sinnige JC, Brinkman K, van den Berk GEL, Blok WL, Lettinga KD, de Regt M, Schouten WEM, Stalenhoef JE, Veenstra J, Vrouenraets SME, Blaauw H, Geerders GF, Kleene MJ, Kok M, Knapen M, van der Meché IB, Mulder-Seeleman E, Toonen AJM, Wijnands S, Wttewaal E, Kwa D, van Crevel R, van Aerde K, Dofferhoff ASM, Henriet SSV, Ter Hofstede HJM, Hoogerwerf J, Keuter M, Richel O, Albers M, Grintjes-Huisman KJT, de Haan M, Marneef M, Strik-Albers R, Rahamat-Langendoen J, Stelma FF, Burger D, Gisolf EH, Hassing RJ, Claassen M, Ter Beest G, van Bentum PHM, Langebeek N, Tiemessen R, Swanink CMA, van Lelyveld SFL, Soetekouw R, van der Prijt LMM, van der Swaluw J, Bermon N, van der Reijden WA, Jansen R, Herpers BL, Veenendaal D, Verhagen DWM, Lauw FN, van Broekhuizen MC, van Wijk M, Bierman WFW, Bakker M, Kleinnijenhuis J, Kloeze E, Middel A, Postma DF, Schölvinck EH, Stienstra Y, Verhage AR, Wouthuyzen-Bakker M, Boonstra A, de Groot-de Jonge H, van der Meulen PA, de Weerd DA, Niesters HGM, van Leer-Buter CC, Knoester M, Hoepelman AIM, Arends JE, Barth RE, Bruns AHW, Ellerbroek PM, Mudrikova T, Oosterheert JJ, Schadd EM, van Welzen BJ, Aarsman K, Griffioen-van Santen BMG, de Kroon I, van Berkel M, van Rooijen CSAM, Schuurman R, Verduyn-Lunel F, Wensing AMJ, Bont LJ, Geelen SPM, Loeffen YGT, Wolfs TFW, Nauta N, Rooijakkers EOW, Holtsema H, Voigt R, van de Wetering D, Alberto A, van der Meer I, Rosingh A, Halaby T, Zaheri S, Boyd AC, Bezemer DO, van Sighem AI, Smit C, Hillebregt M, de Jong A, Woudstra T, Bergsma D, Meijering R, van de Sande L, Rutkens T, van der Vliet S, de Groot L, van den Akker M, Bakker Y, El Berkaoui A, Bezemer M, Brétin N, Djoechro E, Groters M, Kruijne E, Lelivelt KJ, Lodewijk C, Lucas E, Munjishvili L, Paling F, Peeck B, Ree C, Regtop R, Ruijs Y, Schoorl M, Schnörr P, Scheigrond A, Tuijn E, Veenenberg L, Visser KM, Witte EC, Ruijs Y, Van Frankenhuijsen M, Allegre T, Makhloufi D, Livrozet JM, Chiarello P, Godinot M, Brunel-Dalmas F, Gibert S, Trepo C, Peyramond D, Miailhes P, Koffi J, Thoirain V, Brochier C, Baudry T, Pailhes S, Lafeuillade A, Philip G, Hittinger G, Assi A, Lambry V, Rosenthal E, Naqvi A, Dunais B, Cua E, Pradier C, Durant J, Joulie A, Quinsat D, Tempesta S, Ravaux I, Martin IP, Faucher O, Cloarec N, Champagne H, Pichancourt G, Morlat P, Pistone T, Bonnet F, Mercie P, Faure I, Hessamfar M, Malvy D, Lacoste D, Pertusa MC, Vandenhende MA, Bernard N, Paccalin F, Martell C, Roger-Schmelz J, Receveur MC, Duffau P, Dondia D, Ribeiro E, Caltado S, Neau D, Dupont M, Dutronc H, Dauchy F, Cazanave C, Vareil MO, Wirth G, Le Puil S, Pellegrin JL, Raymond I, Viallard JF, Chaigne de Lalande S, Garipuy D, Delobel P, Obadia M, Cuzin L, Alvarez M, Biezunski N, Porte L, Massip P, Debard A, Balsarin F, Lagarrigue M, Prevoteau du Clary F, Aquilina C, Reynes J, Baillat V, Merle C, Lemoing V, Atoui N, Makinson A, Jacquet JM, Psomas C, Tramoni C, Aumaitre H, Saada M, Medus M, Malet M, Eden A, Neuville S, Ferreyra M, Sotto A, Barbuat C, Rouanet I, Leureillard D, Mauboussin JM, Lechiche C, Donsesco R, Cabie A, Abel S, Pierre-Francois S, Batala AS, Cerland C, Rangom C, Theresine N, Hoen B, Lamaury I, Fabre I, Schepers K, Curlier E, Ouissa R, Gaud C, Ricaud C, Rodet R, Wartel G, Sautron C, Beck-Wirth G, Michel C, Beck C, Halna JM, Kowalczyk J, Benomar M, Drobacheff-Thiebaut C, Chirouze C, Faucher JF, Parcelier F, Foltzer A, Haffner-Mauvais C, Hustache Mathieu M, Proust A, Piroth L, Chavanet P, Duong M, Buisson M, Waldner A, Mahy S, Gohier S, Croisier D, May T, Delestan M, Andre M, Zadeh MM, Martinot M, Rosolen B, Pachart A, Martha B, Jeunet N, Rey D, Cheneau C, Partisani M, Priester M, Bernard-Henry C, Batard ML, Fischer P, Berger JL, Kmiec I, Robineau O, Huleux T, Ajana F, Alcaraz I, Allienne C, Baclet V, Meybeck A, Valette M, Viget N, Aissi E, Biekre R, Cornavin P, Merrien D, Seghezzi JC, Machado M, Diab G, Raffi F, Bonnet B, Allavena C, Grossi O, Reliquet V, Billaud E, Brunet C, Bouchez S, Morineau-Le Houssine P, Sauser F, Boutoille D, Besnier M, Hue H, Hall N, Brosseau D, Souala F, Michelet C, Tattevin P, Arvieux C, Revest M, Leroy H, Chapplain JM, Dupont M, Fily F, Patra-Delo S, Lefeuvre C, Bernard L, Bastides F, Nau P, Verdon R, de la Blanchardiere A, Martin A, Feret P, Geffray L, Daniel C, Rohan J, Fialaire P, Chennebault JM, Rabier V, Abgueguen P, Rehaiem S, Luycx O, Niault M, Moreau P, Poinsignon Y, Goussef M, Mouton-Rioux V, Houlbert D, Alvarez-Huve S, Barbe F, Haret S, Perre P, Leantez-Nainville S, Esnault JL, Guimard T, Suaud I, Girard JJ, Simonet V, Debab Y, Schmit JL, Jacomet C, Weinberck P, Genet C, Pinet P, Ducroix S, Durox H, Denes É, Abraham B, Gourdon F, Antoniotti O, Molina JM, Ferret S, Lascoux-Combe C, Lafaurie M, Colin de Verdiere N, Ponscarme D, De Castro N, Aslan A, Rozenbaum W, Pintado C, Clavel F, Taulera O, Gatey C, Munier AL, Gazaigne S, Penot P, Conort G, Lerolle N, Leplatois A, Balausine S, Delgado J, Timsit J, Tabet M, Gerard L, Girard PM, Picard O, Tredup J, Bollens D, Valin N, Campa P, Bottero J, Lefebvre B, Tourneur M, Fonquernie L, Wemmert C, Lagneau JL, Yazdanpanah Y, Phung B, Pinto A, Vallois D, Cabras O, Louni F, Pialoux G, Lyavanc T, Berrebi V, Chas J, Lenagat S, Rami A, Diemer M, Parrinello M, Depond A, Salmon D, Guillevin L, Tahi T, Belarbi L, Loulergue P, Zak Dit Zbar O, Launay O, Silbermann B, Leport C, Alagna L, Pietri MP, Simon A, Bonmarchand M, Amirat N, Pichon F, Kirstetter M, Katlama C, Valantin MA, Tubiana R, Caby F, Schneider L, Ktorza N, Calin R, Merlet A, Ben Abdallah S, Weiss L, Buisson M, Batisse D, Karmochine M, Pavie J, Minozzi C, Jayle D, Castel P, Derouineau J, Kousignan P, Eliazevitch M, Pierre I, Collias L, Viard JP, Gilquin J, Sobel A, Slama L, Ghosn J, Hadacek B, Thu-Huyn N, Nait-Ighil L, Cros A, Maignan A, Duvivier C, Consigny PH, Lanternier F, Shoai-Tehrani M, Touam F, Jerbi S, Bodard L, Jung C, Goujard C, Quertainmont Y, Duracinsky M, Segeral O, Blanc A, Peretti D, Cheret A, Chantalat C, Dulucq MJ, Levy Y, Lelievre JD, Lascaux AS, Dumont C, Boue F, Chambrin V, Abgrall S, Kansau I, Raho-Moussa M, De Truchis P, Dinh A, Davido B, Marigot D, Berthe H, Devidas A, Chevojon P, Chabrol A, Agher N, Lemercier Y, Chaix F, Turpault I, Bouchaud O, Honore P, Rouveix E, Reimann E, Belan AG, Godin Collet C, Souak S, Mortier E, Bloch M, Simonpoli AM, Manceron V, Cahitte I, Hiraux E, Lafon E, Cordonnier F, Zeng AF, Zucman D, Majerholc C, Bornarel D, Uludag A, Gellen-Dautremer J, Lefort A, Bazin C, Daneluzzi V, Gerbe J, Jeantils V, Coupard M, Patey O, Bantsimba J, Delllion S, Paz PC, Cazenave B, Richier L, Garrait V, Delacroix I, Elharrar B, Vittecoq D, Bolliot C, Lepretre A, Genet P, Masse V, Perrone V, Boussard JL, Chardon P, Froguel E, Simon P, Tassi S, Avettand Fenoel V, Barin F, Bourgeois C, Cardon F, Chaix ML, Delfraissy JF, Essat A, Fischer H, Lecuroux C, Meyer L, Petrov-Sanchez V, Rouzioux C, Saez-Cirion A, Seng R, Kuldanek K, Mullaney S, Young C, Zucchetti A, Bevan MA, McKernan S, Wandolo E, Richardson C, Youssef E, Green P, Faulkner S, Faville R, Herman S, Care C, Blackman H, Bellenger K, Fairbrother K, Phillips A, Babiker A, Delpech V, Fidler S, Clarke M, Fox J, Gilson R, Goldberg D, Hawkins D, Johnson A, Johnson M, McLean K, Nastouli E, Post F, Kennedy N, Pritchard J, Andrady U, Rajda N, Donnelly C, McKernan S, Drake S, Gilleran G, White D, Ross J, Harding J, Faville R, Sweeney J, Flegg P, Toomer S, Wilding H, Woodward R, Dean G, Richardson C, Perry N, Gompels M, Jennings L, Bansaal D, Browing M, Connolly L, Stanley B, Estreich S, Magdy A, O'Mahony C, Fraser P, Jebakumar SPR, David L, Mette R, Summerfield H, Evans M, White C, Robertson R, Lean C, Morris S, Winter A, Faulkner S, Goorney B, Howard L, Fairley I, Stemp C, Short L, Gomez M, Young F, Roberts M, Green S, Sivakumar K, Minton J, Siminoni A, Calderwood J, Greenhough D, DeSouza C, Muthern L, Orkin C, Murphy S, Truvedi M, McLean K, Hawkins D, Higgs C, Moyes A, Antonucci S, McCormack S, Lynn W, Bevan M, Fox J, Teague A, Anderson J, Mguni S, Post F, Campbell L, Mazhude C, Russell H, Gilson R, Carrick G, Ainsworth J, Waters A, Byrne P, Johnson M, Fidler S, Kuldanek K, Mullaney S, Lawlor V, Melville R, Sukthankar A, Thorpe S, Murphy C, Wilkins E, Ahmad S, Green P, Tayal S, Ong E, Meaden J, Riddell L, Loay D, Peacock K, Blackman H, Harindra V, Saeed AM, Allen S, Natarajan U, Williams O, Lacey H, Care C, Bowman C, Herman S, Devendra SV, Wither J, Bridgwood A, Singh G, Bushby S, Kellock D, Young S, Rooney G, Snart B, Currie J, Fitzgerald M, Arumainayyagam J, Chandramani S. A highly virulent variant of HIV-1 circulating in the Netherlands. Science 2022; 375:540-545. [PMID: 35113714 DOI: 10.1126/science.abk1688] [Citation(s) in RCA: 30] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
We discovered a highly virulent variant of subtype-B HIV-1 in the Netherlands. One hundred nine individuals with this variant had a 0.54 to 0.74 log10 increase (i.e., a ~3.5-fold to 5.5-fold increase) in viral load compared with, and exhibited CD4 cell decline twice as fast as, 6604 individuals with other subtype-B strains. Without treatment, advanced HIV-CD4 cell counts below 350 cells per cubic millimeter, with long-term clinical consequences-is expected to be reached, on average, 9 months after diagnosis for individuals in their thirties with this variant. Age, sex, suspected mode of transmission, and place of birth for the aforementioned 109 individuals were typical for HIV-positive people in the Netherlands, which suggests that the increased virulence is attributable to the viral strain. Genetic sequence analysis suggests that this variant arose in the 1990s from de novo mutation, not recombination, with increased transmissibility and an unfamiliar molecular mechanism of virulence.
Collapse
Affiliation(s)
- Chris Wymant
- Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | | | - François Blanquart
- Centre for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, INSERM, PSL Research University, Paris, France.,IAME, UMR 1137, INSERM, Université de Paris, Paris, France
| | - Luca Ferretti
- Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Astrid Gall
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK
| | - Matthew Hall
- Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Tanya Golubchik
- Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Margreet Bakker
- Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
| | - Swee Hoe Ong
- Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK
| | - Lele Zhao
- Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - David Bonsall
- Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.,Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Mariateresa de Cesare
- Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - George MacIntyre-Cockett
- Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.,Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Lucie Abeler-Dörner
- Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Jan Albert
- Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.,Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden
| | - Norbert Bannert
- Division for HIV and Other Retroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany
| | - Jacques Fellay
- School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.,Swiss Institute of Bioinformatics, Lausanne, Switzerland.,Precision Medicine Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
| | - M Kate Grabowski
- Department of Pathology, John Hopkins University, Baltimore, MD, USA
| | | | - Huldrych F Günthard
- Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.,Institute of Medical Virology, University of Zurich, Zurich, Switzerland
| | - Pia Kivelä
- Department of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland
| | - Roger D Kouyos
- Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.,Institute of Medical Virology, University of Zurich, Zurich, Switzerland
| | | | - Laurence Meyer
- INSERM CESP U1018, Université Paris Saclay, APHP, Service de Santé Publique, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France
| | - Kholoud Porter
- Institute for Global Health, University College London, London, UK
| | - Matti Ristola
- Department of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland
| | | | - Ben Berkhout
- Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
| | - Paul Kellam
- Kymab Ltd., Cambridge, UK.,Department of Infectious Diseases, Faculty of Medicine, Imperial College London, London, UK
| | - Marion Cornelissen
- Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.,Molecular Diagnostic Unit, Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
| | - Peter Reiss
- Stichting HIV Monitoring, Amsterdam, Netherlands.,Department of Global Health, Amsterdam University Medical Centers, University of Amsterdam and Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands
| | - Christophe Fraser
- Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.,Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Aouba A, Baldolli A, Geffray L, Verdon R, Bergot E, Martin-Silva N, Justet A. Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series. Ann Rheum Dis 2020; 79:1381-1382. [PMID: 32376597 DOI: 10.1136/annrheumdis-2020-217706] [Citation(s) in RCA: 171] [Impact Index Per Article: 42.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2020] [Revised: 04/28/2020] [Accepted: 04/28/2020] [Indexed: 01/16/2023]
Affiliation(s)
- Achille Aouba
- Department of Internal Medicine and Clinical Immunology, CHU Caen, Caen, France
| | | | - Loïk Geffray
- Department of Internal Medicine and Clinical Immunology, CH Lisieux, Lisieux, France
| | - Renaud Verdon
- Department of Infectious Diseases, CHU Caen, Caen, France
| | | | | | | |
Collapse
|
4
|
Puéchal X, Pagnoux C, Baron G, Lifermann F, Geffray L, Quémeneur T, Saraux JL, Wislez M, Cottin V, Ruivard M, Limal N, Aouba A, Bonnotte B, Néel A, Agard C, Cohen P, Terrier B, Le Jeunne C, Mouthon L, Ravaud P, Guillevin L. Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trial. Rheumatology (Oxford) 2020; 58:2107-2116. [PMID: 31056661 DOI: 10.1093/rheumatology/kez139] [Citation(s) in RCA: 28] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2019] [Revised: 03/16/2019] [Indexed: 11/14/2022] Open
Abstract
OBJECTIVE In a previous controlled trial, 1-year adjunction of AZA to glucocorticoids (GC) for patients with non-severe, newly diagnosed eosinophilic granulomatosis with polyangiitis (EGPA) failed to lower remission failure, vasculitis relapse and isolated asthma/rhinosinus exacerbation rates, or cumulative GC use at month (M) 24. The aim of this study was to analyse longer-term outcomes to determine whether subsequent vasculitis relapse or isolated asthma/rhinosinus exacerbation (IARE) rates differed. METHODS After M24, patients were followed prospectively, being treated based on physicians' best judgment. Flares and reasons for increased GC dose or immunosuppressant use were recorded, and reviewed according to randomization group to distinguish vasculitis relapses from IAREs according to EGPA Task Force recommendations. RESULTS Fifty EGPA trial participants were followed for a median (interquartile range) of 6.3 (5.4-7.6) years; two (4%) died 11 months post-inclusion. By M24, vasculitis had relapsed in 21/49 (43%) patients and 14/50 (28%) had IAREs. Another patient died 4.8 years post-inclusion (infection). Among nine patients with subsequent vasculitis relapses, three had a major relapse and three had their first relapse after M24; among 25 patients with later IAREs, 17 occurred after M24. At 5 years, respective vasculitis relapse and IARE rates were 48% (95% CI 34.0, 62.6) and 56% (95% CI 41.7, 70.8), with no between-arm differences (P = 0.32 and 0.13). No entry clinical or biological parameter was associated with these outcomes during follow-up. CONCLUSION These results confirmed that 1-year AZA and GC induction obtained good overall survival but no long-term benefit for non-severe EGPA patients. Vasculitis relapses, occurring mostly during the first 2 years, and IAREs, occurring throughout follow-up, require other preventive treatments. TRIAL REGISTRATION ClinicalTrials.gov, https://clinicaltrials.gov, NCT00647166.
Collapse
Affiliation(s)
- Xavier Puéchal
- National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, APHP, Université Paris Descartes, Paris, France
| | - Christian Pagnoux
- National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, APHP, Université Paris Descartes, Paris, France.,Vasculitis Clinic, Mount Sinai Hospital, Toronto, Ontario, Canada
| | - Gabriel Baron
- Université Paris Descartes, Hôtel-Dieu, APHP, Paris, France
| | | | | | | | | | - Marie Wislez
- Hôpital Tenon, APHP, Université Pierre et Marie Curie, Paris, France
| | - Vincent Cottin
- Hôpital Louis-Pradel, Lyon and UMR754, Université Claude Bernard Lyon 1, Lyon, France
| | - Marc Ruivard
- Centre Hospitalier Universitaire Estaing, Clermont-Ferrand, France
| | - Nicolas Limal
- Hôpital Henri-Mondor, Université Paris-Est Créteil, APHP, Créteil, France
| | - Achille Aouba
- Centre Hospitalier Universitaire Côte de Nacre, Caen, France
| | | | - Antoine Néel
- Centre Hospitalier Universitaire Hôtel-Dieu, Nantes, France
| | | | - Pascal Cohen
- National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, APHP, Université Paris Descartes, Paris, France
| | - Benjamin Terrier
- National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, APHP, Université Paris Descartes, Paris, France
| | - Claire Le Jeunne
- National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, APHP, Université Paris Descartes, Paris, France
| | - Luc Mouthon
- National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, APHP, Université Paris Descartes, Paris, France
| | | | - Loïc Guillevin
- National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, APHP, Université Paris Descartes, Paris, France
| | | |
Collapse
|
5
|
Abisror N, Mekinian A, Dechartres A, Groh M, Berezne A, Noel N, Morati C, Haroche J, Hunault-Berger M, Agard C, Ackermann F, Geffray L, Jeandel PY, Trouillier S, Quemeneur T, Dufour JF, Lamaury I, Lhote F, Lefèvre G, Fain O, Kahn JE. Abnormal T-cell phenotype in episodic angioedema with hypereosinophilia (Gleich's syndrome): frequency, clinical implication and prognosis. J Am Acad Dermatol 2019; 88:e243-e250. [PMID: 30738125 DOI: 10.1016/j.jaad.2019.02.001] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2018] [Revised: 01/28/2019] [Accepted: 02/01/2019] [Indexed: 11/29/2022]
Abstract
BACKGROUND Episodic Angioedema with eosinophilia (EAE, Gleich's syndrome) is a rare disorder consisting of recurrent episodes of angioedema, hypereosinophilia and frequent elevated serum Immunoglobin M. METHODS We conducted a retrospective multicenter nationwide study regarding the clinical spectrum and therapeutic management of patients with EAE in France. RESULTS Thirty patients were included with a median age at diagnosis of 41 years [5-84]. The median duration of each crisis was 5.5 days [1-90] with swelling affecting mainly the face and the upper limbs. Total serum IgM levels were increased in 20 patients (67%). Abnormal T-cell immunophenotypes were detected in 12 patients (40%) among which 5 (17%) showed evidence of clonal TCR γ gene rearrangement. Median follow-up duration was 53 months [31-99]. The presence of an abnormal T-cell population was the sole factor associated with a shorter time to flare (hazard ratio 4.15 [CI 95% 1.18-14.66; p=0.02). At last follow-up, 3 patients (10%) were able to withdraw all treatments and 11 (37%) were in clinical and biological remission with less than 10 mg of daily prednisone. CONCLUSION EAE is a heterogeneous condition that encompasses several disease forms. Although patients usually respond well to glucocorticoids, those with evidence of abnormal T-cell phenotype have a shorter time to flare.
Collapse
Affiliation(s)
- Noémie Abisror
- AP-HP, Hôpital Saint Antoine, service de Médecine Interne, Département Hospitalo-Universitaire Inflammation-Immunopathologie-Biotherapie (DHU i2B) (DHU i2B), Faculté de Médecine Sorbonne Université, F-75012, Paris, France.
| | - Arsène Mekinian
- AP-HP, Hôpital Saint Antoine, service de Médecine Interne, Département Hospitalo-Universitaire Inflammation-Immunopathologie-Biotherapie (DHU i2B) (DHU i2B), Faculté de Médecine Sorbonne Université, F-75012, Paris, France
| | - Agnès Dechartres
- Sorbonne Université, Inserm U1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Département Biostatistique, santé publique, information médicale - Hôpital Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France
| | - Matthieu Groh
- Service de Médecine Interne, Université Versailles Saint-Quentin-en-Yvelines, Centre de Référence des Syndromes Hyperéosinophiliques (CEREO), Hôpital Foch, Suresnes, France
| | - Alice Berezne
- Service de Médecine Interne, CH Annecy Genevois, Annecy, France
| | - Nicolas Noel
- Department of Internal Medicine, Assistance-Publique Hôpitaux de Paris Paris XI University, Hôpital Bicêtre Le Kremlin-Bicêtre, France
| | - Chafika Morati
- Service de Médecine Interne, CH Annecy Genevois, Annecy, France
| | - Julien Haroche
- Department of Internal Medicine, French Reference Centre for Rare Autoimmune Systemic Diseases, e3m Institute, Assistance-Publique Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris, France ; Paris VI University (UPMC), Sorbonne Universités, Paris, France
| | - Mathilde Hunault-Berger
- Maladies du Sang, CHU Angers, CRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France
| | | | - Felix Ackermann
- Service de Médecine Interne, Université Versailles Saint-Quentin-en-Yvelines, Centre de Référence des Syndromes Hyperéosinophiliques (CEREO), Hôpital Foch, Suresnes, France
| | - Loïk Geffray
- Service de médecine interne, Centre Hospitalier, Lisieux, France
| | - Pierre-Yves Jeandel
- Service de Médecine Interne, Centre Hospitalier Universitaire de Nice, Nice, France
| | | | - Thomas Quemeneur
- Département de Néphrologie et Département de Médecine Interne, Centre Hospitalier de Valenciennes, France
| | - Jean-François Dufour
- Service de Médecine Interne et Post-Urgence, Centre Hospitalier de Bourg-en-Bresse
| | - Isabelle Lamaury
- Inserm-CIC 1424 et Service de Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Pointe-à-Pitre, Pointe-à-Pitre, France
| | - François Lhote
- Service de Médecine Interne, Hôpital de Saint-Denis, Saint-Denis, France
| | - Guillaume Lefèvre
- U995, LIRIC - Lille Inflammation Research International Center ; INSERM, U995 ; Département de Médecine Interne et Immunologie Clinique, Centre National de Référence Maladies Systémiques et Auto-immunes Rares (Sclérodermie Systémique), Centre de Référence des Syndromes Hyperéosinophiliques (CEREO); Institut d'Immunologie, CHU Lille, Université de Lille, Lille, France
| | - Olivier Fain
- AP-HP, Hôpital Saint Antoine, service de Médecine Interne, Département Hospitalo-Universitaire Inflammation-Immunopathologie-Biotherapie (DHU i2B) (DHU i2B), Faculté de Médecine Sorbonne Université, F-75012, Paris, France
| | - Jean Emmanuel Kahn
- Service de Médecine Interne, Université Versailles Saint-Quentin-en-Yvelines, Centre de Référence des Syndromes Hyperéosinophiliques (CEREO), Hôpital Foch, Suresnes, France
| | | |
Collapse
|
6
|
Puéchal X, Pagnoux C, Baron G, Lifermann F, Geffray L, Quéméneur T, Saraux J, Wislez M, Cottin V, Ruivard M, Limal N, Guillevin L. Suivi à long-terme des patients atteints de granulomatose éosinophilique avec polyangéite inclus dans l’étude CHUSPAN2 ayant évalué l’intérêt de l’adjonction de l’azathioprine à la corticothérapie en traitement d’induction. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
7
|
Testaert H, Mombrun M, Klein S, Fouquet H, Gérard M, Legros A, Ray A, Auzary C, Jeanjean C, Geffray L. Rémission transitoire sous ibrutinib d’un syndrome de Bing-Neel au cours d’une maladie de Waldenström. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.300] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
8
|
Puéchal X, Pagnoux C, Baron G, Quémeneur T, Néel A, Agard C, Lifermann F, Liozon E, Ruivard M, Godmer P, Limal N, Mékinian A, Papo T, Ruppert AM, Bourgarit-Durand A, Bienvenu B, Geffray L, Terrier B, Groh M, Le Jeunne C, Mouthon L, Ravaud P, Guillevin L. LB0002 Does Adding Azathioprine To Glucocorticoid Induction Increase The Remission Rate and Prevent Relapses in Patients with Systemic Necrotizing Vasculitides without Poor-Prognosis Factors? A Multicenter, Double-Blind Randomized Controlled Trial. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.6204] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
9
|
de Boysson H, Liozon E, Lambert M, Parienti JJ, Artigues N, Geffray L, Boutemy J, Ollivier Y, Maigné G, Ly K, Huglo D, Hachulla E, Hatron PY, Aouba A, Manrique A, Bienvenu B. 18F-fluorodeoxyglucose positron emission tomography and the risk of subsequent aortic complications in giant-cell arteritis: A multicenter cohort of 130 patients. Medicine (Baltimore) 2016; 95:e3851. [PMID: 27367985 PMCID: PMC4937899 DOI: 10.1097/md.0000000000003851] [Citation(s) in RCA: 68] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
Previous studies reported a 2- to 17-fold higher risk of aortic complications (dilation or dissection) in patients with giant-cell arteritis (GCA). We aimed to determine whether or not GCA patients with large-vessel involvement demonstrated by positron emission tomography with F-fluorodeoxyglucose combined with computed tomography (FDG-PET/CT) have a higher risk of aortic complications. We conducted a retrospective multicenter study between 1995 and 2014. Patients were included if they fulfilled at least 3 American College of Rheumatology criteria for GCA, or 2 criteria associated with extratemporal biopsy-proven giant-cell vasculitis; they underwent at least 1 FDG-PET/CT scan at diagnosis or during follow-up; and the morphology of the aorta was assessed by medical imaging at diagnosis. Patients with an aortic complication at the time of diagnosis were excluded. Of the 130 patients included [85 women (65%), median age 70 (50-86)], GCA was biopsy proven in 77 (59%). FDG-PET/CT was performed at diagnosis in 63 (48%) patients and during the follow-up period in the 67 (52%) remaining patients. FDG-PET/CT was positive in 38/63 (60%) patients at diagnosis and in 31/67 (46%) patients when performed during follow-up (P = NS). One hundred four patients (80%) underwent at least 1 morphological assessment of the aorta during follow-up. Nine (9%) patients developed aortic complications (dilation in all and dissection in 1) at a median time of 33 (6-129) months after diagnosis. All of them displayed large-vessel inflammation on previous FDG-PET/CT. A positive FDG-PET/CT was significantly associated with a higher risk of aortic complications (P = 0.004).In our study, a positive FDG-PET/CT was associated with an increased risk of aortic complications at 5 years.
Collapse
Affiliation(s)
- Hubert de Boysson
- Department of Internal Medicine, Caen University Hospital, Basse-Normandie University
- Correspondence: Hubert de Boysson, Department of Internal Medicine, Caen University Hospital, Avenue de la Côte de Nacre, 14000 Caen, France (e-mail: )
| | - Eric Liozon
- Department of Internal Medicine, Limoges University Hospital
| | - Marc Lambert
- Department of Internal Medicine, Lille University Hospital
| | | | | | - Loïk Geffray
- Department of Internal Medicine, Lisieux Hospital
| | - Jonathan Boutemy
- Department of Internal Medicine, Caen University Hospital, Basse-Normandie University
| | - Yann Ollivier
- Department of Internal Medicine, Caen University Hospital, Basse-Normandie University
| | - Gwénola Maigné
- Department of Internal Medicine, Caen University Hospital, Basse-Normandie University
| | - Kim Ly
- Department of Internal Medicine, Limoges University Hospital
| | - Damien Huglo
- Department of Nuclear Medicine, Lille University Hospital
| | - Eric Hachulla
- Department of Internal Medicine, Lille University Hospital
| | | | - Achille Aouba
- Department of Internal Medicine, Caen University Hospital, Basse-Normandie University
| | - Alain Manrique
- Department of Nuclear Medicine, Caen University Hospital, Normandie University France
| | - Boris Bienvenu
- Department of Internal Medicine, Caen University Hospital, Basse-Normandie University
| |
Collapse
|
10
|
de Boysson H, Johnson A, Hablani N, Hajlaoui W, Auzary C, Geffray L. Tocilizumab in the treatment of a polyostotic variant of fibrous dysplasia of bone: Fig. 1. Rheumatology (Oxford) 2015; 54:1747-9. [DOI: 10.1093/rheumatology/kev221] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
|
11
|
de Boysson H, Lechapt-Zalcman E, Salaun V, Johnson A, Auzary C, Geffray L. Biopsy-proven muscular involvement of lymphomatoid granulomatosis assessed by (18)FDG-PET Scan. Joint Bone Spine 2015; 82:372-3. [PMID: 25623523 DOI: 10.1016/j.jbspin.2014.12.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2014] [Accepted: 12/04/2014] [Indexed: 10/24/2022]
Affiliation(s)
- Hubert de Boysson
- Department of Internal Medicine, centre hospitalier Robert-Bisson, 4, rue Roger-Aini, 14100 Lisieux, France; Department of Internal Medicine, centre hospitalier et universitaire de la Côte-de-Nacre, Caen, France.
| | | | - Véronique Salaun
- Hematology laboratory, centre hospitalier et universitaire de la Côte-de-Nacre, Caen, France
| | - Alison Johnson
- Department of Internal Medicine, centre hospitalier Robert-Bisson, 4, rue Roger-Aini, 14100 Lisieux, France
| | - Christophe Auzary
- Department of Internal Medicine, centre hospitalier Robert-Bisson, 4, rue Roger-Aini, 14100 Lisieux, France
| | - Loïk Geffray
- Department of Internal Medicine, centre hospitalier Robert-Bisson, 4, rue Roger-Aini, 14100 Lisieux, France
| |
Collapse
|
12
|
Touzot M, Poisson J, Faguer S, Ribes D, Geffray L, François H, Karras A, Cacoub P, Durrbach A, Saadoun D. Efficacité et tolérance au long cours d’un traitement par rituximab dans la maladie des anticorps anti-membrane basale glomérulaire. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.10.127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
13
|
Joalland F, de Boysson H, Darnige L, Johnson A, Jeanjean C, Cheze S, Augustin A, Auzary C, Geffray L. [Seronegative antiphospholipid syndrome, catastrophic syndrome, new anticoagulants: learning from a difficult case report]. Rev Med Interne 2014; 35:752-6. [PMID: 25217794 DOI: 10.1016/j.revmed.2014.04.012] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2013] [Revised: 02/18/2014] [Accepted: 04/18/2014] [Indexed: 10/24/2022]
Abstract
INTRODUCTION The diagnosis of the antiphospholipid syndrome (APS) is based on clinical and biological criteria including the persistent presence of antiphospholipid antibodies and thrombotic events or pregnancy morbidity. Heparins relayed by vitamin K antagonists (VKA) are the gold standard treatment for thrombosis. CASE REPORT We report a 17-year-old man who presented with an initially seronegative antiphospholipid syndrome, in whom the diagnosis was late, only obtained after anticoagulation withdrawing, when a catastrophic antiphospholipid syndrome (CAPS) with cutaneous lesions and disseminated intravascular coagulation syndrome occurred. For personal convenience, this patient was initially treated with fondaparinux followed by a new oral anticoagulant (rivaroxaban) before to return to the conventional VKA treatment. CONCLUSION The "seronegative" APS is a controversial concept reflecting the heterogeneity of antigenic targets for aPL. This diagnosis may be considered after a rigorous work-up, with the help of haemostasis laboratories testing new emerging aPL assays. In APS, the new anticoagulants represent an attractive option needing nevertheless prospective studies to evaluate their safety and efficacy. Lupus anticoagulant detection in patients treated by new oral anticoagulants is not easy by usually recommended coagulation tests.
Collapse
Affiliation(s)
- F Joalland
- Service de médecine interne, centre hospitalier Robert-Bisson, 4, rue Roger-Aini, 14100 Lisieux, France
| | - H de Boysson
- Service de médecine interne, centre hospitalier Robert-Bisson, 4, rue Roger-Aini, 14100 Lisieux, France
| | - L Darnige
- Service d'hématologie biologique, hôpital européen Georges-Pompidou, AP-HP, Paris, France
| | - A Johnson
- Service de médecine interne, centre hospitalier Robert-Bisson, 4, rue Roger-Aini, 14100 Lisieux, France
| | - C Jeanjean
- Service de médecine interne, centre hospitalier Robert-Bisson, 4, rue Roger-Aini, 14100 Lisieux, France
| | - S Cheze
- Service d'hématologie, CHU Côte-de-Nacre, 14000 Caen, France
| | - A Augustin
- Cabinet d'anatomopathologie Saint-Louis, 14, rue Gaston-Lavalley, 14000 Caen, France
| | - C Auzary
- Service de médecine interne, centre hospitalier Robert-Bisson, 4, rue Roger-Aini, 14100 Lisieux, France
| | - L Geffray
- Service de médecine interne, centre hospitalier Robert-Bisson, 4, rue Roger-Aini, 14100 Lisieux, France.
| |
Collapse
|
14
|
Audemard A, Lamy T, Bareau B, Sicre F, Suarez F, Truquet F, Salaun V, Macro M, Verneuil L, Lobbedez T, Castrale C, Boutemy J, Cheze S, Geffray L, Schleinitz N, Rey J, Lazaro E, Guillevin L, Bienvenu B. Vasculitis associated with large granular lymphocyte (LGL) leukemia: presentation and treatment outcomes of 11 cases. Semin Arthritis Rheum 2014; 43:362-6. [PMID: 24326032 DOI: 10.1016/j.semarthrit.2013.07.002] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2013] [Revised: 07/01/2013] [Accepted: 07/08/2013] [Indexed: 11/18/2022]
Abstract
OBJECTIVE The association between vasculitis and large granular lymphocyte (LGL) leukemia has rarely been reported or investigated. Thus, we assessed the clinical and biological phenotypes of LGL leukemia associated with vasculitis. RESULTS We studied a series of 11 patients displaying LGL leukemia associated with vasculitis (LAV). The mean age at diagnosis of LGL leukemia was 60.3 years; there were nine women and two men. The mean follow-up period was 45 months. The main LGL lineage was T-LGL (10 patients), and only one NK-LGL was identified. Clinical and biological features of T-LGL leukemia were compared with those from the 2009 French T-LGL registry. We did not find any relevant differences except that patients with LAV were predominantly female (p < 0.05). The most frequently observed vasculitis was cryoglobulinemia (n = 5). Three patients presented with cutaneous leukocytoclastic angiitis, two patients had ANCA-negative microscopic polyangiitis, and one patient had giant cell arteritis. The main clinical features involved the skin, e.g., purpura (91%), arthralgia (37%), peripheral neuritis (27%), and renal glomerulonephritis (18%). The most frequent histologic finding was leucocytoclastic vasculitis (54%). The rate of complete remission was high; i.e., 80%. A minority of patients had a vasculitis relapse (27%). Three patients (27%) died; one death was related to LGL leukemia (acute infection) and the two other deaths were related to vasculitis (both with heart failure). CONCLUSION We conclude that vasculitis is overrepresented in the population of LGL patients, LAV predominantly affects women, vasculitis preferentially affects the small vessels, and LAV has high rate of complete response.
Collapse
|
15
|
de Boysson H, Liozon E, Lambert M, Parienti JJ, Artigues N, Geffray L, Boutemy J, Manrique A, Bienvenu B. La tomographie par émission de positons dans la maladie de Horton : un outil pronostique pour les complications aortiques. À propos d’une série rétrospective multicentrique de 133 patients. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.03.061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
16
|
de Boysson H, Jonhson A, Paoli A, Auzary C, Jeanjean C, Geffray L. Dysplasie fibreuse des os : 2 cas trompeurs ; première observation d’efficacité du tocilizumab. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.10.307] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
17
|
Audemard A, Lamy T, Boutemy J, Lazaro E, Geffray L, schleinitz N, Verneuil L, Guillevin L, Bienvenu B. AB0438 Vasculitis associated with large granular lymphocyte leukemia : presentation and treatment outcomes. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.2760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
18
|
de Boysson H, Chèze S, Chapon F, Le Mauff B, Auzary C, Geffray L. Eosinophilic fasciitis with paroxysmal nocturnal hemoglobinuria. Joint Bone Spine 2013; 80:208-10. [DOI: 10.1016/j.jbspin.2012.07.008] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2012] [Accepted: 07/05/2012] [Indexed: 11/28/2022]
|
19
|
Audemard A, Lamy T, Boutemy J, Lazaro E, Geffray L, Schleinitz N, Salaun V, Guillevin L, Bienvenu B. Vascularites associées à des leucémies à grands lymphocytes granuleux (LGL) : à propos d’une série rétrospective de 11 patients. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.10.052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
20
|
Abstract
Lymphomatoid granulomatosis, described in 1972 by Liebow, is a rare, Epstein-Barr virus (EBV)-associated lymphoproliferative disorder, involving the lung, and often the skin or the central nervous system. It could have a systemic course making its diagnosis difficult. Controversy still remains about precise taxonomy and lymphomatoid granulomatosis is classified as a lymphoma, whose severity extends from indolent forms to aggressive large B cell lymphomas. Histology is essential and shows characteristically an inflammatory angiocentric infiltrate, composed with polymorphous mononucleated cells containing a varying number of large atypical CD20-positive B-lymphocytes within a background of numerous small reactive CD3-positive T-lymphocytes, often associated with necrosis. In situ hybridization often shows EBV RNA within atypical B-cells. Atypical large B-lymphocytes proportion and to a lesser degree EBV-positive B-lymphocytes proportion allow to classify the disease (grade I to III) and have a prognostic value. An aggressive form of B lymphoma occurs in 7 to 47% of cases during lymphomatoid granulomatosis course. Moreover, grade III diseases share numerous characteristics of lymphoma and often require chemotherapy. Several conditions mimic lymphomatoid granulomatosis, and include various hematologic malignancies (large B-cells lymphomas, T/NK lymphomas, post-immunodepression lymphoproliferative disorders) or granulomatosis with polyangiitis. The objective of this article is to review the clinical, radiological, histological and therapeutic characteristics of this rare disorder.
Collapse
Affiliation(s)
- H de Boysson
- Service de médecine interne, centre hospitalier Robert-Bisson, 4, rue Roger-Aini, 14107 Lisieux, France.
| | | |
Collapse
|
21
|
de Boysson H, Février J, Jeanjean C, Nicolle A, Auzary C, Geffray L. Une cause de pneumothorax à connaître : l’endométriose thoracique. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.03.328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
22
|
Audemard A, Verger H, Gendrot A, Jeanjean C, Auzary C, Geffray L. Association pyoderma gangrenosum, pustulose sous-cornée et abcès aseptiques spléniques : « une maladie neutrophilique ». Rev Med Interne 2012; 33:e28-30. [DOI: 10.1016/j.revmed.2011.04.006] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2010] [Revised: 08/16/2010] [Accepted: 04/16/2011] [Indexed: 12/24/2022]
|
23
|
Wechsler B, Canuel C, Geffray L, Hanslik T, Kettaneh A, Pavic M, Vignes S, Lévesque H, Pouchot J. Communications orales à l’honneur présentées au cours du 64e congrès de la Société nationale française de médecine interne (Paris, 14–16 décembre 2011). Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.02.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
24
|
Brugière C, Lamy T, Nicolle A, Jeanjean C, Auzary C, Geffray L. Importance de l’imagerie dans le diagnostic des aortites inflammatoires : trois observations. Rev Med Interne 2011. [DOI: 10.1016/j.revmed.2011.10.098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
25
|
|
26
|
Geffray L, Le Palud P, Gendrot A, Boissinot L, Poynard JP, Adicolle JM, Auzary C, Jeanjean C. Traitement de la maladie de Still de l’adulte par tocilizumab : deux nouvelles observations. Rev Med Interne 2010. [DOI: 10.1016/j.revmed.2010.10.166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
27
|
Piette AM, Beaudouin C, Charles P, Ackermann F, François D, Leport J, Guth A, Blétry O, Kahn JE, Geffray L. Sale temps pour une grenouille. Rev Med Interne 2010; 31:570-4. [DOI: 10.1016/j.revmed.2010.06.004] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2010] [Accepted: 06/08/2010] [Indexed: 12/23/2022]
|
28
|
Audemard A, Verger H, Gendrot A, Auzary C, Geffray L. Association pyoderma gangrenosum – pustulose sous cornée – abcès aseptiques spléniques : « une maladie neutrophilique ». Rev Med Interne 2010. [DOI: 10.1016/j.revmed.2010.03.164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
29
|
Le Gallou T, Gendrot A, Clément C, Auzary C, Jeanjean C, Geffray L. Maladie de Still de l’adulte et atteinte neurologique…. Rev Med Interne 2009. [DOI: 10.1016/j.revmed.2009.10.386] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
30
|
Geffray L. [Therapeutic news in multiple myeloma. Congress of the French National Society of Internal Medicine, December 2008, Bordeaux]. Rev Med Interne 2009; 30:465-8. [PMID: 19349101 DOI: 10.1016/j.revmed.2009.02.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- L Geffray
- Service de médecine interne, hôpital Robert-Bisson, 14100 Lisieux, France.
| |
Collapse
|
31
|
Geffray L, Auzary C, Poynard JP, Gras G, Besselièvre T, Jeanjean C. Un lupus de diagnostic retardé chez une femme de 65 ans. Rev Med Interne 2008. [DOI: 10.1016/j.revmed.2008.10.279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
32
|
Geffray L. Hémoglobinurie paroxystique nocturne. Rev Med Interne 2008; 29:957-61. [DOI: 10.1016/j.revmed.2008.08.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
33
|
Martin Silva N, Geffray L, Gras G, Auzary C, Jeanjean C, Poynard J, Paris C. Un cas de variant myéloïde de syndrome hyperéosinophilique à transcrit de fusion FIP1L1-PDGFRα ; efficacité de l’imatinib. Rev Med Interne 2008. [DOI: 10.1016/j.revmed.2008.03.241] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
34
|
Gras G, Geffray L, Parienti J, Jeanjean C, Goubin P, Feret P, Verdon R. K-08 Les routiers : une profession à risque de dépistage tardif du VIH. Med Mal Infect 2008. [DOI: 10.1016/s0399-077x(08)73162-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
35
|
Paciencia M, Dediu S, Hablani N, Morice A, Laplaud AL, Paris C, Delbarre JC, Leroy D, Geffray L. [Lupus vorax and tuberculous coxitis]. Ann Dermatol Venereol 2007; 134:596-7. [PMID: 17657199 DOI: 10.1016/s0151-9638(07)89284-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
Affiliation(s)
- M Paciencia
- Service de Médecine Interne, Centre Hospitalier de Lisieux
| | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Jeanjean C, Geffray L, Auzary C, Poynard JP. Un groupe à risque d'infection VIH à ne pas méconnaître: les chauffeurs-routiers. Rev Med Interne 2007. [DOI: 10.1016/j.revmed.2007.03.193] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
37
|
Geffray L, Artigues N, Boutemy J, Poynard JP, Paris C, Armand P, Bonnefoy L, Alric L. La fermière ne dépassait plus la barrière! Rev Med Interne 2005; 26 Suppl 2:S200-2. [PMID: 16129145 DOI: 10.1016/s0248-8663(05)80025-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
- L Geffray
- Service de médecine interne, centre hospitalier Robert-Bisson, Lisieux, France
| | | | | | | | | | | | | | | |
Collapse
|
38
|
Affiliation(s)
- L Geffray
- Service de médecine interne, centre hospitalier Robert-Bisson, 4, rue Roger-Aini, 14100 Lisieux, France
| | | | | | | |
Collapse
|
39
|
Geffray L, des Vernettes J, Poynard J, Paris C, Bachelet C, Delmas P. Fièvre et pace-maker? Ne pas oublier le boîtier! Rev Med Interne 2003. [DOI: 10.1016/s0248-8663(03)80534-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
40
|
Verdon R, Geffray L, Collet T, Huet H, Parienti JJ, Debruyne M, Vergnaud M, Bazin C. Vertebral osteomyelitis due to Bartonella henselae in adults: a report of 2 cases. Clin Infect Dis 2002; 35:e141-4. [PMID: 12471592 DOI: 10.1086/344791] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2002] [Revised: 08/13/2002] [Indexed: 11/03/2022] Open
Abstract
We describe 2 adult patients (1 of whom was infected with human immunodeficiency virus) with osteomyelitis due to Bartonella henselae. Diagnosis was established on the basis of direct identification of the microorganism in one case and seroconversion in the other. Both patients recovered completely within 3 months.
Collapse
Affiliation(s)
- Renaud Verdon
- Service de Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire Côte-de-Nacre, 14033 Caen Cedex, France.
| | | | | | | | | | | | | | | |
Collapse
|
41
|
Grateau G, Geffray L, Veyssier-Belot C. [First scientific meeting of CRI (Rheumatism and Inflammation Club) under the patronage of FNSIM (French National Society of Internal Medicine) and FSR(French Society of Rheumatology) Paris, May 4, 2002]. Rev Med Interne 2002; 23:805-7. [PMID: 12428480 DOI: 10.1016/s0248-8663(02)00706-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
MESH Headings
- Antibodies, Antineutrophil Cytoplasmic
- Antibodies, Monoclonal/adverse effects
- Antibodies, Monoclonal/therapeutic use
- Antirheumatic Agents/adverse effects
- Antirheumatic Agents/therapeutic use
- Arthritis, Rheumatoid/drug therapy
- Arthritis, Rheumatoid/immunology
- France
- Giant Cell Arteritis/drug therapy
- Giant Cell Arteritis/etiology
- Humans
- Infliximab
- Internal Medicine
- Mutation
- Rheumatology
- Scleroderma, Systemic/drug therapy
- Scleroderma, Systemic/etiology
- Societies, Medical
- Syndrome
- Tumor Necrosis Factor-alpha/antagonists & inhibitors
- Tumor Necrosis Factor-alpha/genetics
- Tumor Necrosis Factor-alpha/physiology
- Vasculitis, Leukocytoclastic, Cutaneous/drug therapy
- Vasculitis, Leukocytoclastic, Cutaneous/etiology
Collapse
Affiliation(s)
- G Grateau
- Service de médecine interne, hôpital Roger-Bisson, 4, rue Roger-Aini, 14100 Lisieux, France
| | | | | |
Collapse
|
42
|
Madic A, Lecltaze A, Barbier S, Geffray L, Poynard J. Thrombopénie immuno-allergique aux dérivés de l'acétylcystéine ? Ne pas se précipiter en matièère d'imputabilité! Rev Med Interne 2002. [DOI: 10.1016/s0248-8663(02)80358-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
43
|
Cacoub P, Geffray L, Rosenthal E, Perronne C, Veyssier P, Raguin G. Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997. Clin Infect Dis 2001; 32:1207-14. [PMID: 11283811 DOI: 10.1086/319747] [Citation(s) in RCA: 116] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2000] [Revised: 09/07/2000] [Indexed: 01/30/2023] Open
Abstract
Several studies have suggested that the progression of hepatitis C virus (HCV) infection is more severe in patients infected by the human immunodeficiency virus (HIV). Two national retrospective multicenter cohort surveys were performed in France that included 17,487 HIV-infected patients during 1995 and 26,497 during 1997. The following data was evaluated: total number of deaths; number of deaths linked to AIDS, cirrhosis, or hepatocellular carcinoma (HCC); and number of deaths related to other (non-HCV--linked) causes. In 1995, the causes of death were as follows: AIDS, 1307 (7.47%); cirrhosis or HCC, 21 (0.12%); and other (non-HCV--linked) causes, 99 (0.56%). In 1997, the causes of deaths were as follows: AIDS, 459 (1.73%); cirrhosis or HCC 36 (0.13%); and other (non-HCV--linked) causes, 48 (0.18%). Comparative results between the 1995 and 1997 surveys showed a dramatic decrease in AIDS-related mortality rates (7.47% vs. 1.73%; P<.001) but not in HCV-related mortality rates (0.06% vs. 0.07%; P=.79). In France, despite the high prevalence of HCV infection in HIV-positive patients, the mortality rate in 1995 and 1997 caused by HCV-related cirrhosis or HCC was low.
Collapse
Affiliation(s)
- P Cacoub
- Dept of Internal Medicine, Hôpital La Pitié-Salpêtrière, Paris, France.
| | | | | | | | | | | |
Collapse
|
44
|
|
45
|
Belot CV, Geffray L. [Vaccination. Meeting "Vaccinations 2000" Compiègne, June 22 2000]. Rev Med Interne 2000; 21:933-7. [PMID: 11109587] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
Affiliation(s)
- C V Belot
- Service de médecine interne, centre hospitalier Poissy-Saint-Germain, France
| | | |
Collapse
|
46
|
Geffray L, Poynard JP, Collet T, Armand P, Verdon R. [A "diagnosis of goldsmith"]. Rev Med Interne 2000; 21 Suppl 3:326s-329s. [PMID: 10916845 DOI: 10.1016/s0248-8663(00)89259-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Affiliation(s)
- L Geffray
- Service de médecine interne, centre hospitalier Robert-Bisson, Lisieux
| | | | | | | | | |
Collapse
|
47
|
Geffray L, Rosenthal E, Cacoub P, Perronne C, Veyssier P, Raguin G, Cevallos R, Patey O, Bouchard O, Loury I, Delarocque E, Goujard C, Estavoyer JM, Dupont C, Grappin M, Morand P, Laurichesse H, Vuitton D. [1977 mortality rate in HIV-infected patients presenting with hepatitis C cirrhosis. Results of the GERMIVC multicenter survey conducted in French departments of internal medicine or infectious disease]. Rev Med Interne 1999; 20:1082-7. [PMID: 10635069 DOI: 10.1016/s0248-8663(00)87521-9] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
PURPOSE Hepatitis C (HCV) has a high prevalence (10-30%) among human immunodeficiency virus (HIV)-infected patients. However, little information is available regarding the impact of hepatitis C on survival. The objective of our study was to determine the incidence of hepatitis C-related deaths in HIV-HCV co-infected patients. METHODS The study was a retrospective (1-year), multicenter cohort survey conducted in 63 departments of either internal medicine or infectious diseases in France. It included 26,497 HIV-infected patients, of whom 4,465 (16.8%) presented coinfection due to the hepatitis C virus. The following parameters were studied for the year 1997: total number of deaths, number of deaths related to either AIDS, cirrhosis, hepatocellular carcinoma, or other causes. RESULTS Among the 26,497 patients, 543 deaths (incidence: 2%) were observed in 1997; 543 deaths were due to AIDS (incidence: 1.7%), 36 to cirrhosis and/or hepatocellular carcinoma (incidence: 0.13%), and 48 (incidence: 0.18%) to another cause. In the subgroup including 4,465 HIV-HCV-coinfected patients, 29 deaths (incidence: 0.64%) were due to either HCV-related cirrhosis or hepatocellular carcinoma. These results were compared with those of a previous similar survey conducted in 1995, before the era of highly active antiretroviral therapy. The only significant difference is the dramatic regression of deaths due to AIDS. CONCLUSION The impact of hepatitis C virus on the mortality among HIV-infected patients whose follow-up took place in departments of either internal medicine or infectious diseases in France was very low in 1997. The expected increase in the life span in these patients could modify these results in the future, due to recent improvements in the HIV infection treatment.
Collapse
|
48
|
Abstract
INTRODUCTION Domestic pets can transmit numerous infections, including bacterial, parasitic, fungal, and viral diseases. This paper reports the epidemiologic, clinical, therapeutic and prophylactic data of these zoonoses. CURRENT KNOWLEDGE AND KEY POINTS The routes of transmission are various. Bites and scratches are the most common health hazards and result in localized infections. Pasteurellosis, various aerobic and anaerobic infections, and cat-scratch disease are predominant. Bites are treated by cleaning the wound, rabies and tetanus prophylaxis, and the appropriate use of antibiotics. Other infections are transmitted through cutaneous, mucous, digestive or respiratory routes, by direct contact with the pets, excreta, or by arthropods. The most common are gastrointestinal (campylobacter, salmonella, yersinia, parasites, etc), dermatologic (dermatophytoses, scabies, cutaneous larva migraines, etc.), respiratory (psittacosis, etc.), and multisystemic (toxoplasmosis, toxocariasis, leishmaniosis). Certain people are at high risk for diverse diseases: small children (toxocariasis, helminthiasis), pregnant women (toxoplasmosis), and immunodeficient patients (cryptosporidiosis, salmonellosis, systemic pasteurellosis). These infectious diseases can be partly prevented by avoiding contact with diseased animals, and by washing the hands following exposure to pets or pet-derived excreta. Specific vaccines for humans and pets, as well as worming pets regularly, form an important part of the prevention. Veterinarians must discourage the keeping of wild or exotic animals as pets. FUTURE PROSPECTS AND PROJECTS National health survey institutions and new communication systems can improve our knowledge about the real epidemiology of pet-transmitted zoonoses.
Collapse
Affiliation(s)
- L Geffray
- Service de médecine interne, Centre hospitalier de Lisieux, France
| |
Collapse
|
49
|
Affiliation(s)
- L Geffray
- Service de médecine interne, hôpital de Compiègne
| | | | | | | |
Collapse
|
50
|
Cevallos R, Del Pozo M, Zylberait D, Naepels P, Veyssier P, Geffray L, Vorhauer W, Gobert MG, Caignault L, Carelli C, Roseto A. Detection of micrometastasis in 31 patients with breast cancer by RT-PCR and immunomagnetic separation (ISM) techniques. Adv Exp Med Biol 1999; 451:245-6. [PMID: 10026880 DOI: 10.1007/978-1-4615-5357-1_39] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/10/2023]
Affiliation(s)
- R Cevallos
- DICA Division d'Immuno-Cytologie Appliquée UTC Compiègne, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|